Share on StockTwits

OptimizeRx Co.(NDA) (NASDAQ:OPRX) posted its quarterly earnings results on Tuesday. The company reported ($0.04) earnings per share for the quarter, missing the analysts’ consensus estimate of $0.01 by $0.05, AnalystRatings.NET reports.

On the ratings front, analysts at Zacks reiterated an “outperform” rating on shares of OptimizeRx Co.(NDA) in a research note on Friday, April 4th. They now have a $4.00 price target on the stock.

OptimizeRx Co (NASDAQ:OPRX) opened at 1.72 on Tuesday. OptimizeRx Co has a one year low of $0.86 and a one year high of $2.12. The stock’s 50-day moving average is $1.69 and its 200-day moving average is $1.6. The company’s market cap is $40.6 million.

OptimizeRx Corporation provides platforms to help patients better afford and comply with their medicines and healthcare products, while offering pharmaceutical and healthcare companies effective ways to expand patient awareness, access and adherence to their brands.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.